1Wang C L,Wu Y T,Liu C A,et al.Kawasaki disease:immunity geneties[J].Pediatrie,2005,24(11):998-1004.
2Matsubara K,Fukaya T.The role of superantigens of group A streptococcus and staphylococcus aurous in Kawasaki disease[J].Curropin Infect Dis,2007,20(3):298-303.
3Yeung R S.The etiology of Kawasaki disease:a super antigen-mediated process[J].Prog Pediat Cardio,2004,19(2):115-122.
5Wang G B,Li C R,Zu Y,et al.The role of activation of toll-likereceptors in immunological pathogenesis of Kawasaki disease[J].Er Ke Za Zhi,2006,44(5):333-336.
6Rowley A H,Shulman S T.New developments in the search for the etiologic agnt of Kawasaki disease[J].Curropin Pediatr,2007,19(1):71-74.
7Park J A,Shin K S,Kim Y W,et al.Polymorphism of matrix metallo-proteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease[J].Korean Med SCI,2005,20(4):607-611.
8Jaffery T K,Morell N W.Molecular and cellular basis of pulmonary ascular remodeling in pulmonary hypertension[J].Prog Cardiovasc Dis,2002,45(3):173-202.
10Gavin P J,Crawford S E,Shulman S T,et al.System ic arterial expresssion of matrix metallop roteinases 2 and 9 in acute Kawasaki disease[J].Vascbiol,2003,3(4):576-581.
2Elmore JR,Keister BF,Franklin DP,et al.Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.Ann Vasc Surg,1998,12:221-228.
3Kim S,Singh M,Huang J,et al.Matrix metalloproteinas-9 in cerebral aneurysms.Neurosurg,1997,41:642.
4Kai H,Ikeda H,Yasukawa H,et al.Peripheral blood levels of matrix metalloproteinases-2 and 9 are elevated in patients with acute myocardial syndrome.J Am Coll Cardiol,1998,32:368-372.
5Amano S,Hazama F,Hamashima Y.Pathology of Kawasaki disease:I.Pathology and morphogenesis of the vascular changes.Jpn Circ J,1979,43:633-643.
7Okada Y,Watanabe S,Nakanishi I,et al.Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteases.FEBS Lett,1988,229:157-160.
8Gavin PJ,Crawford SE,Shulman ST,et al.Matrix destruction and angiogenesis in coronary artery aneurysma in Kawasaki disease.Pediatr Res,2003,52:169.
9Ghislain O,Philippe E,Van den Steen BD,et al.Gelatinase B functions as regulator and effecter in leukocyte biology.J Leukoc Biol,2001,69:851-859.
10Bond M,Chase AJ,Baker AH,et al.Inhibition of transcription factor NF-kappa B reduces matrix metalloproteinase-1,-3 and -9 production by vascular smooth muscle cells.Cardiovasc Res,2001,50:556-565.
